Evance Biosciences Private Limited

Evance Biosciences Private Limited - chemicals in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24239TG2021PTC155753 Incorporated 08 October 2021 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2025
₹1.56 Cr
▲ 123% YoY
Net profit · FY 2025
₹2.31 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹3.12 Lakh
EBITDA margin 2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Evance Biosciences Private Limited

Data last updated:

Evance Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 October 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2021PTC155753.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Monalisa Padhi and Rama Chandra Panigrahi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 3 – 228/106/1 Rehmath Nagar Sk Nagar, Hyderabad, Telangana, India – 500045.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.56 Cr, a growth of 123% compared to the previous year. For the same year it recorded a net profit of ₹2.31 Lakh (net margin 1.5%) and EBITDA of ₹3.12 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 86% over three years.

Evance Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0044333).

Company details

CIN U24239TG2021PTC155753
Registration Number 155753
Incorporation Date 08 October 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0044333

Recognitions & Rankings of Evance Biosciences

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-TS-02-0044333

Contact details

Evance Biosciences Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    8 – 3 – 228/106/1 Rehmath Nagar Sk Nagar, Hyderabad, Telangana, India – 500045
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Evance Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Evance Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Evance Biosciences Private Limited, buy the company report.

Financials of Evance Biosciences Private Limited

FY 2025 filings available

Evance Biosciences Private Limited reported revenue of ₹1.56 Cr (up 123% YoY) for FY 2025.

Revenue · FY 2025
₹1.56 Cr ▲ 123%
Net profit · FY 2025
₹2.31 Lakh margin 1.5%
EBITDA · FY 2025
₹3.12 Lakh margin 2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 123%
3 years · compounded
▲ 86%
EBITDA CAGR growth
1 year
▲ 115%
3 years · compounded
▲ 66%

Revenue has grown at a compounded annual rate (CAGR) of 86% over three years, including 123% growth in the latest year. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.12 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin2%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Evance Biosciences Private Limited, buy the company report.

Board of directors of Evance Biosciences Private Limited

Evance Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Monalisa PadhiDirector08 Oct 20215 Years 0 MonthsCurrent
Rama Chandra PanigrahiDirector01 Jun 20233 Years 4 MonthsCurrent

Peer comparison

Evance Biosciences Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Omics Biosciences Private Limited₹1.59 Cr (FY 2025)211.0%Eluru, Andhra Pradesh, India
Evance Biosciences Private Limitedthis company₹1.56 Cr (FY 2025)₹2.31 Lakh1.5%123.0%Hyderabad, Telangana, India
Oprl Biosciences Private Limited₹1.47 Cr (FY 2024)28.0%Chennai, Tamil Nadu, India
Recues Biosciences Private Limited₹1.39 Cr (FY 2024)46.0%Bangalore, Karnataka, India
Acuere Biosciences Private Limited₹1.32 Cr (FY 2025)7.0%Pune, Maharashtra, India

To see the full peer comparison of Evance Biosciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Evance Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Evance Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Evance Biosciences Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Laxman Panigrahy ceased to be Director on 01 Jun 2023.

AGM
Evance Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Evance Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Laxman Panigrahy ceased to be Director.
Appointed
Rama Chandra Panigrahi was appointed as Director.
Appointed
Monalisa Padhi was appointed as Director.
Incorporation
08 Oct 2021
Evance Biosciences Private Limited was registered on 08 Oct 2021 with Roc Hyderabad & aged 5 years 21 days as per MCA records.

Frequently asked questions

Evance Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 October 2021 (5+ years old) and is registered under CIN U24239TG2021PTC155753.

Evance Biosciences has 2 current directors:

The latest financial statements of Evance Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Evance Biosciences is U24239TG2021PTC155753. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Evance Biosciences was incorporated on 08 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Evance Biosciences by revenue are Omics Biosciences Private Limited, Oprl Biosciences Private Limited, Recues Biosciences Private Limited, Acuere Biosciences Private Limited, all in the Biotechnology industry (Biosciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Laxman Panigrahy ceased to be Director on 01 Jun 2023. Rama Chandra Panigrahi was appointed as Director on 01 Jun 2023. Monalisa Padhi was appointed as Director on 08 Oct 2021.

Yes, Evance Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0044333).

The registered office of Evance Biosciences is at 8 – 3 – 2281061 Rehmath Nagar Sk Nagar, Hyderabad, Telangana, India – 500045.

Evance Biosciences operates in the chemicals industry, in the manufacturing segment.

Evance Biosciences can be reached at its registered office: 8 – 3 – 2281061 Rehmath Nagar Sk Nagar, Hyderabad, Telangana, India – 500045.